Medical fish skin company Kerecis closes $3m convertible note
Ísafjörður based Kerecis, that creates fish skin based products to help with healing of wounds, recently announced it had sold a $3m convertible note to its current investors. All the largest investors in the company participated, and the note was oversubscribed.
Kerecis was in NSA Ventures portfolio until 2014 when the fund sold its 26% stake to a group of investors that included the founder. The purchase price was undisclosed.